Sionna Therapeutics, Inc. · NASDAQ:SION
Cloonan Michael received 109,025 Sionna Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 17, 2026 · Filed Sep 18, 2026
On Sep 17, 2026, Cloonan Michael (Director, President & CEO) received 109,025 Sionna Therapeutics, Inc. shares as an award, leaving 656,368 shares. Filed Sep 18, 2026 (Form 4).
- Awarded
- 109,025 shares
- Holding after
- 656,368 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Common Stock | Award | 109,025 | 656,368 | Direct |
Source
Related
- Sionna Therapeutics, Inc.
- Cloonan Michael
- Sionna Therapeutics, Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Sep 21, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 21, 2026
- Form 4 · Ridloff Elena · Sep 18, 2026
- Form 4 · McKee Charlotte · Sep 18, 2026
- Form 4 · Fitzpatrick Jennifer · Sep 18, 2026